Integra Therapeutics
Integra Therapeutics engineers next-generation gene writing tools, combining CRISPR precision with viral integrase and transposase efficiency to treat genetic diseases.
About Integra Therapeutics
Integra Therapeutics, founded in 2020, is a biotechnology company developing next-generation gene editing tools aimed at curing genetic diseases. The company combines the precision of CRISPR systems with the gene transfer efficiency of viral integrases and transposases to enable highly efficient and programmable gene delivery. By harnessing natural mechanisms evolved to introduce large DNA fragments into the genome together with sequence-specific DNA-binding proteins Integra Therapeutics achieves unprecedented accuracy and efficiency in targeted gene integration, advancing the future of genomic medicine.



